search
for
 About Bioline  All Journals  Testimonials  Membership  News  Donations


Tropical Journal of Pharmaceutical Research
Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria
ISSN: 1596-5996
EISSN: 1596-9827
Vol. 8, No. 1, 2009, pp. 19-26
Bioline Code: pr09004
Full paper language: English
Document type: Research Article
Document available free of charge

Tropical Journal of Pharmaceutical Research, Vol. 8, No. 1, 2009, pp. 19-26

 en Protective effect of methanol-methylene chloride extract of Terminalia glaucescens leaves on streptozotocin-induced diabetes in mice
Njomen, Guy BSN; Kamgang, René; Soua, Petit RN; Oyono, Jean LE & Njikam, Njifutie

Abstract

Purpose: Terminalia glaucescens (Combretaceae) is traditionally used in Cameroon in the treatment of diabetes. The anti-hyperglycemic effect of the methanol-methylene chloride extract of the leaves of this plant was investigated in streptozotocin (STZ)-induced diabetic mice.
Methods: Diabetes was induced in mice by a daily dose of STZ (45 mg kg-1 body weight i.p.) for 5 days. From one day before STZ injection, normal and diabetic-test mice received one oral dose of the extract (100 mg kg-1 or 300 mg kg-1 body weight) daily for 15 days. The effect of the extract on body weight gain, food and water intake, plasma metabolites (glucose and lipids) and insulin levels was investigated.
Results: Diabetic control mice and diabetic mice pre-treated with 100 mg kg-1 extract showed body weight loss, marked (P< 0.001) polyphagia and polydipsia, high plasma metabolites and glucose (P< 0.001), non-esterified fatty acids (NEFA) (P< 0.05), triglycerides (TG) (P< 0.05), and cholesterol (P< -1 0.05) and low insulin (P< 0.001) levels. Normal control, i.e., normal treated mice and 300 mg kg-1 extract pre-treated diabetic mice, presented normal weight gain, normal food and water intake, normal plasma metabolites and insulin levels, and did not exhibit very significant changes (P<0.1) in blood glucose level..
Conclusion: These results indicate that the extract of T. glaucescens leaf at a dose of 300 mg kg-1 protects against STZ-induced diabetic effects and could explain the traditional use of this plant in the management of diabetes.

Keywords
Terminalia glaucescens, streptozotocin, diabetes mellitus, glycemia, lipemia.

 
© Copyright 2009 - TJPR Faculty of Pharmacy, University of Benin, Benin City, Nigeria
Alternative site location: http://www.tjpr.org

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2022, Site last up-dated on 19-Jan-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Internet Data Center of Rede Nacional de Ensino e Pesquisa, RNP, Brazil